Clinical Trial Update: Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 safety study update for ACT-PFK-158, 2HCl in patients with advanced solid malignancies; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ACT-PFK-158, 2HCl

Snippet

Sponsor: Advanced Cancer Therapeutics | Conditions: Cancer | Phase 1 | Status: UNKNOWN